Showing 71 - 80 of 184,349
Persistent link: https://www.econbiz.de/10012506948
Persistent link: https://www.econbiz.de/10012488757
Our calculations indicate that currently proposed U.S. policies to reduce pharmaceutical prices, though particularly beneficial for low-income and elderly populations, could dramatically reduce firms' investment in highly welfare-improving R&D. The U.S. subsidizes the worldwide pharmaceutical...
Persistent link: https://www.econbiz.de/10014576635
Persistent link: https://www.econbiz.de/10012881711
, the pharmaceutical market has been increasingly targeted by different kinds of regulation, focussing on both the supply …
Persistent link: https://www.econbiz.de/10014196884
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10014150467
This paper deals with the various kinds of regulatory bodies present in the pharmaceutical industry and also covers the aspects of environmental, intellectual property rights & taxation laws which govern the pharmaceutical industry in India
Persistent link: https://www.econbiz.de/10014154335
best weak in this industry. This paper tests the hypothesis that regulation of manufacturer prices and of retail pharmacy … markets (US, UK, Canada, Germany) but that regulation undermines generic competition in strict regulatory systems (France …, Italy, Japan). Regulation of retail pharmacy further constrains competition in France, Germany and Italy. Regulation thus …
Persistent link: https://www.econbiz.de/10014038394
Persistent link: https://www.econbiz.de/10013478070
Persistent link: https://www.econbiz.de/10014426082